Cancer drug takes on Alzheimer's: small study hints at hope
NCT ID NCT04070378
First seen Nov 15, 2025 · Last updated May 11, 2026 · Updated 25 times
Summary
This pilot study tested daratumumab, a cancer drug, in 16 people with mild to moderate Alzheimer's disease. The goal was to see if it could improve thinking and memory. The study was small and open-label, meaning everyone knew they were getting the drug, so results are very early and not conclusive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Litwin-Zucker Research Center
Manhasset, New York, 11030, United States
Conditions
Explore the condition pages connected to this study.